The current institutional shareholding score of ImmuCell Corp is 3.00, ranking 94 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 23.86%, representing a quarter-over-quarter increase of 17.57%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.68% of shares outstanding, with 0.13% increase in holdings.